Orthopedic Devices Market Size & Share 2026-2035

Orthopedic Devices Market Size

The global orthopedic devices market was estimated at USD 60.6 billion in 2025. The market is expected to grow from USD 63 billion in 2026 to USD 92.2 billion in 2035, at a CAGR of 4.3% during the forecast period, according to the latest report published by Global Market Insights Inc. The market is driven by numerous factors, such as innovation in biologics and regenerative solutions, augmented incidence of orthopedic diseases, among other factors.

Orthopedic devices are specialized medical tools, implants, and instruments designed to diagnose, prevent, and treat musculoskeletal disorders, injuries, and deformities. They include joint reconstruction implants, trauma fixation systems, spinal devices, and sports medicine solutions, aiming to restore mobility, reduce pain, improve functionality, and enhance patients’ overall quality of life.

The orthopedic devices industry offers cutting-edge healthcare solutions to payers, providers, life sciences organizations, and healthcare technology firms to enhance regulatory compliance, patient outcomes, and operating efficiency. Solutions range from joint reconstruction devices, trauma fixation systems, spinal implants, sports medicine solutions, and digital health technologies that facilitate surgical accuracy, rehabilitation, and quality of care. Some of the most prominent players in the market are DePuy Synthes (Johnson & Johnson), Stryker, Zimmer Biomet, Smith & Nephew, and Medtronic. These players continue to maintain their competitive edge by continuously developing new product offerings, taking advantage of robust global distribution channels, establishing strategic alliances, and spending heavily in research and development to cater to changing clinical demands and increase their market share.

The orthopedic devices market is experiencing steady growth, driven by a combination of demographic, clinical, and technological factors. A primary driver is the rising prevalence of musculoskeletal disorders such as osteoarthritis, osteoporosis, and traumatic injuries, which continue to increase the demand for advanced orthopedic interventions. The rapid expansion of the global geriatric population further supports market growth, as elderly individuals are more susceptible to degenerative bone diseases, fractures, and joint-related complications requiring implants or surgical procedures.

The rise in sports injuries and road accidents has increased demand for trauma fixation devices and sports medicine solutions. Technological advancements such as minimally invasive surgery, robotics-assisted procedures, 3D-printed implants, and smart orthopedic devices are enhancing surgical precision and recovery. Growing patient awareness and early treatment preference, especially in emerging markets, are accelerating adoption, collectively driving market growth and transforming orthopedic care globally.

The increasing number of orthopedic surgical procedures, particularly in developed countries, is a significant driver of the orthopedic devices industry. This rise is primarily due to the high prevalence of joint-related disorders, improved access to advanced healthcare infrastructure, and growing patient awareness of surgical treatment options. According to the American Joint Replacement Registry (AJRR), a total of 3,149,042 primary and revision hip and knee arthroplasty procedures were recorded between 2012 and 2022, with the majority comprising primary knee (51.0%) and primary hip (33.4%) arthroplasties. This substantial procedure volume highlights the growing demand for joint reconstruction devices and associated technologies. Additionally, the increasing adoption of surgical interventions, supported by favorable reimbursement policies and technological advancements, is further accelerating the demand for orthopedic devices, thereby contributing to sustained market growth.

Orthopedic Devices Market Trends

Advancements in orthopedic device technologies and design innovations are playing a critical role in driving market growth by improving surgical precision, enhancing implant longevity, and enabling better patient outcomes. Continuous innovation across implants, surgical systems, and digital technologies is transforming orthopedic care toward more efficient and minimally invasive procedures.

• Robotic-assisted and computer-guided surgical systems are revolutionizing orthopedic procedures by improving accuracy and consistency. Technologies such as Stryker’s Mako SmartRobotics system and Zimmer Biomet’s ROSA Knee system enable surgeons to create patient-specific surgical plans using 3D imaging and intraoperative data, ensuring precise implant positioning and optimized joint alignment.  These systems reduce surgical variability, minimize soft tissue damage, and improve recovery timelines.
• Personalization and AI-driven solutions are further enhancing orthopedic care. The integration of artificial intelligence and advanced imaging allows for customized implants and data-driven surgical decision-making, improving procedural planning and outcomes. Newer systems incorporate analytics platforms to support intraoperative adjustments and post-operative performance tracking, contributing to better long-term patient management.
• Minimally invasive techniques and improved instrumentation are also gaining traction, supported by innovations in surgical tools and navigation systems. Enhanced ergonomics, smaller incisions, and advanced visualization technologies reduce surgical trauma, lower complication rates, and shorten hospital stays.
• For instance, Stryker’s Triathlon Gold knee system incorporates advanced materials and design features to improve durability and accommodate patients with metal sensitivities, while continuing to integrate with robotic-assisted platforms for enhanced procedural accuracy.
• Collectively, these technological advancements highlight a strong industry focus on precision, personalization, and improved patient outcomes. The convergence of robotics, advanced materials, and digital technologies is expected to further accelerate innovation, making technological progress a key factor supporting sustained growth in the market.

Orthopedic Devices Market Analysis

Based on the product, the orthopedic devices market is segmented into joint reconstruction devices, spinal devices, trauma fixation devices, orthobiologics, arthroscopic and sports medicine devices, and other products. The joint reconstruction devices segment has asserted its dominance in the market by securing a significant market share of 39.2% in 2025, driven by the rising prevalence of osteoarthritis, hip & knee replacements, and an aging population. The segment is expected to exceed USD 33.4 billion by 2035, growing at a CAGR of 3.5% during the forecast period.

• The joint reconstruction devices segment is the largest and most dominant in the  market, driven primarily by the rising incidence of osteoarthritis and other degenerative joint conditions that significantly impact mobility and quality of life.
• The segment’s strong growth is driven by the rising prevalence of osteoarthritis, rheumatoid arthritis, and sports-related injuries, coupled with a rapidly aging population that is more susceptible to joint degeneration. Additionally, the increasing number of orthopedic procedures, supported by growing awareness, improved access to healthcare, and favorable reimbursement policies in developed markets, is further fueling demand for joint reconstruction devices.
• Improvements in biomaterials, prosthetic design, and 3D printing technology have enhanced implant durability, patient comfort, and surgical accuracy, further facilitating adoption. Increasing awareness of early surgical interventions, combined with improved reimbursement policies in developed markets, has encouraged greater patient willingness to undergo joint reconstruction.
• The spinal devices segment is projected to expand at 4.1% CAGR to reach USD 22.2 billion by 2035. Growth in this segment is fueled by the rising prevalence of spinal disorders such as degenerative disc disease, scoliosis, and spinal stenosis, which are increasingly common due to aging populations and lifestyle factors.
• The adoption of minimally invasive spine surgeries has surged, as patients and healthcare providers prefer procedures that reduce recovery time, minimize complications, and shorten hospital stays. Technological advancements in spinal implants, including motion-preserving devices, bioresorbable materials, and image-guided surgical systems, have improved surgical outcomes and broadened treatment options.
• The trauma fixation devices segment is projected to expand at 5% CAGR to reach USD 15.4 billion by 2035. This segment is primarily driven by the rising global incidence of fractures and traumatic injuries resulting from road accidents, sports activities, falls, and occupational hazards. Additionally, the growing elderly population, with age-related osteoporosis and fragility fractures, has further accelerated demand for internal and external fixation devices. Advances in biomaterials, such as titanium and bioresorbable polymers, have enhanced device durability, biocompatibility, and patient outcomes, making these devices increasingly preferred by surgeons.
• The arthroscopic and sports medicine devices segment is projected to expand at 5.6% CAGR to reach USD 9.2 billion by 2035. The arthroscopic and sports medicine devices segment comprises instruments and implants used in minimally invasive procedures for the diagnosis and treatment of joint injuries and soft tissue conditions. This includes arthroscopic instruments such as scopes, shavers, fluid management systems, cannulas, and portals, as well as sports medicine implants such as anchors, sutures, interference screws, and synthetic ligaments used in procedures like ACL reconstruction, rotator cuff repair, meniscus repair, and labral stabilization. These devices enable precise visualization, repair, and reconstruction of joint structures, making them essential in modern orthopedic practice.

• The hospitals segment represents the largest end use category in the market, as hospitals are the primary centers for performing complex orthopedic surgeries such as joint replacements, spinal procedures, and trauma fixation. These facilities are equipped with advanced surgical infrastructure, including robotic-assisted systems, imaging technologies, and specialized orthopedic operating rooms, enabling high procedural volumes and improved clinical outcomes.
• The segment’s growth is driven by the increasing burden of musculoskeletal disorders, rising number of inpatient surgeries, and availability of skilled healthcare professionals. Additionally, hospitals benefit from favorable reimbursement frameworks and the ability to handle high-risk and emergency cases, reinforcing their dominance in the adoption of advanced orthopedic devices.
• The ambulatory surgical centers segment is projected to expand at 3.4% CAGR to reach USD 31.9 billion by 2035. ASCs are witnessing significant growth in the orthopedic devices industry due to their cost-effectiveness, shorter patient stay, and convenience for less complex orthopedic procedures. These centers are increasingly equipped with advanced minimally invasive technologies that enable outpatient joint arthroscopy, spinal interventions, and fracture management.
• Rising demand for same-day surgeries, coupled with patient preference for quicker recovery and reduced hospital-associated risks, is fueling the expansion of ASCs. Furthermore, supportive government initiatives to reduce healthcare costs and advancements in anesthesia and pain management have accelerated the adoption of orthopedic devices in these centers.
• With the growing shift toward value-based healthcare and emphasis on efficiency, ASCs are emerging as an important setting for orthopedic procedures, particularly in developed markets.
• The other end users segment is projected to expand at 5.2% CAGR to reach USD 9 billion by 2035. The others segment, including specialty orthopedic clinics and rehabilitation centers, plays a supportive role in the orthopedic care continuum by focusing on diagnosis, minor procedures, post-operative care, and long-term rehabilitation. These facilities are increasingly adopting orthopedic devices such as braces, supports, and certain minimally invasive treatment solutions to enhance patient recovery and mobility.
• Growth in this segment is driven by the rising emphasis on outpatient care, increasing demand for rehabilitation services, and the need for continuous monitoring and management of chronic musculoskeletal conditions. Although smaller in revenue contribution compared to hospitals and ASCs, this segment is expanding steadily due to the growing focus on patient-centric and decentralized care delivery models.

 North America Orthopedic Devices Market

The North America market accounted for a majority share of 55.4% in 2025 and is anticipated to show notable growth over the forecast period.

• The U.S. market size reached USD 30.6 billion in 2025, growing from USD 29.9 billion in 2024, and is anticipated to grow at a CAGR of 2.9% from 2026 to 2035.
• North America leads the orthopedic devices industry due to its advanced healthcare infrastructure, high healthcare spending, and strong adoption of new medical technologies. The region also has a large elderly population with a high prevalence of arthritis, osteoporosis, and degenerative joint diseases, which drives significant demand for orthopedic interventions. Notably, according to the Centers for Disease Control and Prevention (CDC), about 33 million U.S. adults were living with osteoarthritis as of 2024, highlighting the substantial disease burden and the resulting need for joint reconstruction and orthopedic care.
• High rates of obesity and sports-related injuries further increase the need for joint reconstruction, spinal fixation, and trauma fixation devices. Growing awareness of minimally invasive procedures, coupled with the rising adoption of robotic-assisted surgeries and orthobiologics, continues to strengthen market growth.
• Additionally, ongoing research collaborations, regulatory approvals, and clinical trials in orthopedic care create a robust growth ecosystem, ensuring that North America maintains its leading position in the market.

Europe Orthopedic Devices Market

Europe accounted for a significant share of the market and was valued at USD 12.2 billion in 2025.

• The European market is largely influenced by the aging population in the region, which greatly elevates the incidence of musculoskeletal diseases like osteoarthritis, osteoporosis, and spinal disorders. Increasing cases of sports injuries and road accidents also fuel the demand for orthopedic treatments.
• Technological innovations, such as minimally invasive procedures, robotic surgeries, and 3D-printed implants, are improving surgical success and patient recovery, eventually driving the market even higher. Sophisticated healthcare infrastructure and favorable reimbursement policies in nations like the UK, France, and Italy are supporting wider use of advanced orthopedic devices.
• Additionally, increasing awareness of early diagnosis and treatment, coupled with government initiatives to improve orthopedic care accessibility, supports market expansion. The trend toward outpatient and ambulatory surgical centers in Europe is also encouraging the use of portable and cost-efficient orthopedic devices, making the region a lucrative market for both established and emerging players.

Asia Pacific Orthopedic Devices Market

The Asia Pacific market accounted for a substantial share of the market and was valued at USD 10.5 billion in 2025.

• The Asia Pacific market is expanding rapidly, driven by a rising incidence of musculoskeletal disorders, a growing population, and increased cases of trauma from road accidents and sports injuries. Developing healthcare infrastructure, expanding hospital networks, and greater availability of orthopedic surgical procedures are supporting market adoption in the region.
• Growing awareness of orthopedic treatment options, enhanced diagnostic capabilities, and supportive government policies to improve healthcare accessibility are further fueling market growth. The increasing demand for joint replacement surgeries, spinal implants, and minimally invasive procedures is attracting investments from global orthopedic device manufacturers.
• Additionally, the rise of medical tourism in countries such as India, Thailand, and Malaysia, combined with cost-effective treatment options compared to Western markets, is boosting the adoption of orthopedic devices. Favorable reimbursement policies and rising healthcare expenditure further contribute to the robust growth trajectory of the Asia Pacific market.

Latin America Orthopedic Devices Market

The Latin America market is anticipated to exhibit remarkable growth during the analysis period.

• Latin America is emerging as a growing market for orthopedic devices, driven by rising musculoskeletal disorders, an aging population, and increasing incidences of road traffic accidents and sports-related injuries across key countries such as Brazil, Mexico, and Argentina.
• The region has witnessed increasing investments in healthcare infrastructure, including the development of modern hospitals and specialized orthopedic centers, which is boosting the adoption of advanced orthopedic devices such as joint reconstruction implants, spinal devices, and trauma fixation systems.
• Moreover, growing awareness of orthopedic care, coupled with improving healthcare coverage and insurance penetration, is encouraging patients to seek timely surgical interventions. Technological advancements, including the adoption of robotic-assisted systems and advanced biomaterials, are further improving surgical outcomes and supporting market expansion.
• The combination of increasing procedure volumes, ongoing infrastructure development, and rising disposable income levels is collectively driving steady growth of the orthopedic devices industry in Latin America.

Middle East and Africa Orthopedic Devices Market

The Middle East and Africa market is expected to experience substantial growth over the analysis timeframe.

• The market in the Middle East & Africa (MEA) is driven by the rising prevalence of orthopedic disorders, including arthritis, spinal conditions, and traumatic injuries, along with a high incidence of road traffic accidents and a gradually expanding elderly population across the region. Governments in key countries such as Saudi Arabia, UAE, and South Africa are increasingly focusing on healthcare modernization and infrastructure development, supporting the adoption of advanced orthopedic devices.
• Growing public and private healthcare expenditure, along with improving medical insurance coverage, is enhancing access to orthopedic procedures such as joint replacement, spinal surgeries, and trauma fixation. The increasing establishment of specialty hospitals and orthopedic centers is further strengthening the demand for advanced devices across urban healthcare systems.
• Technological advancements, including minimally invasive surgical techniques, robotic-assisted systems, navigation technologies, and 3D-printed implants, are being increasingly adopted in tertiary care settings, improving surgical precision, reducing recovery time, and enhancing patient outcomes.
• Overall, the combination of infrastructure development, increasing access to healthcare services, technological adoption, and growing patient awareness is positioning the MEA region as a steadily growing market within the global orthopedic devices landscape.

Orthopedic Devices Market Share

• The market is highly dynamic, with key players such as DePuy Synthes (Johnson & Johnson), Stryker, Zimmer Biomet, Smith & Nephew, and Medtronic, which collectively account for 55% share of the global market.

• Leading players in the market are actively expanding their geographic footprint and strengthening distribution networks to enhance market penetration and accessibility. Strategic collaborations with hospitals, ambulatory surgical centers, and regional distributors, along with targeted acquisitions, are enabling companies to broaden their product portfolios and improve service delivery across both developed and emerging markets. These initiatives are critical for addressing rising procedural demand and ensuring the availability of advanced orthopedic implants, surgical systems, and related technologies across diverse healthcare settings.
• For instance, major companies such as Stryker, Zimmer Biomet, Smith+Nephew, and DePuy Synthes (Johnson & Johnson) are focusing on expanding their orthopedic portfolios through continuous product innovation and strategic partnerships. Companies like Stryker and Zimmer Biomet are advancing robotic-assisted surgical platforms such as Mako and ROSA systems, while others are strengthening their presence in joint reconstruction and sports medicine through acquisitions and portfolio expansion. These efforts support improved supply chain efficiency, enhance responsiveness to clinical demand, and enable companies to address the growing need for high-precision and minimally invasive orthopedic solutions.
• Furthermore, market participants are increasingly aligning their strategies with evolving healthcare needs, including the rising demand for minimally invasive procedures, improved patient outcomes, and operational efficiency. The integration of orthopedic devices with digital technologies, surgical navigation systems, robotics, and AI-enabled analytics is enabling more precise and efficient surgical interventions. In addition, increasing emphasis on implant longevity, cost optimization, and patient-specific solutions, including 3D-printed implants and smart devices, is influencing product development and innovation strategies across the market.
• Collectively, these strategic initiatives by leading players are reshaping competitive dynamics, accelerating technological adoption, and strengthening the long-term growth trajectory of the market.

Orthopedic Devices Market Companies

A few of the prominent players operating in the global orthopedic devices industry include:

• aap Implantate
• Arthrex
• ATEC
• B. Braun
• ConforMIS
• CONMED
• DePuy Synthes (J&J)
• Enovis
• Globus Medical
• Integra
• Medacta
• Medtronic
• MicroPort Scientific
• Smith & Nephew
• Stryker
• TriMed
• Waldemar
• Zimmer Biomet        

•  DePuy Synthes (Johnson & Johnson)

DePuy Synthes dominates the market with a share of 14.5%. It stands out for its comprehensive orthopedic portfolio, including joint reconstruction, trauma, spinal, and sports medicine solutions. Its USPs include cutting-edge implant technologies, minimally invasive surgical systems, advanced digital planning tools, and strong global distribution, enabling improved patient outcomes and streamlined surgical efficiency.

•  Stryker

Stryker’s USPs lie in its innovative orthopedic devices, particularly in joint reconstruction, trauma, and spinal care. The company excels with technologically advanced implants, robotic-assisted surgery systems, and digital surgical planning platforms, combined with strong clinician support and global reach, ensuring precision, efficiency, and enhanced recovery in orthopedic procedures.

• Zimmer Biomet

Zimmer Biomet is a leading player in the orthopedic devices industry, offering a broad portfolio of joint reconstruction, sports medicine, and trauma products. The company focuses on innovation through technologies such as the ROSA robotic-assisted system, enabling precise, patient-specific surgical procedures. With a strong global presence and continued investment in digital and implant solutions, Zimmer Biomet remains a key contributor to market growth.

Orthopedic Devices Industry News

• In January 2025, Stryker (US) finalized an agreement to sell its spinal implant business segment to Viscogliosi Brothers, LLC (US), leading to the creation of a new entity, VB Spine, LLC, which will oversee the acquired spinal implant operations.
• In December 2024, Zimmer Biomet (US) received FDA clearance for the Persona Solution PPS Femur, a total knee implant designed specifically for patients sensitive to bone cement or metal, expanding treatment options in orthopedic knee replacement procedures.
• In December 2024, Zimmer Biomet (US) received FDA 510(k) clearance for its OsseoFit Stemless Shoulder System, a total shoulder replacement solution designed to provide patients with improved joint function and surgeons with a versatile, stemless implant option.
• In July 2024, Smith+Nephew (UK) partnered with Healthcare Outcomes Performance Company (US) to provide healthcare professionals, patients, and ASCs with enhanced solutions by leveraging the company’s digital analytics platform for improved outcomes and operational efficiency.

The orthopedic devices market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in (USD Million) from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Joint reconstruction devices
  • Knee replacement
  • Hip replacement
  • Shoulder replacement
  • Ankle replacement
  • Other joint reconstruction devices
• Spinal devices
• Trauma fixation devices
• Orthobiologics
• Arthroscopic and sports medicine devices
• Other products

Market, By End Use

• Hospitals and clinics
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE